Previously, it has been demonstrated that a higher CD8+ T cell infiltrate in the skin is correlated with better prognosis in patients across plaque-stage MF, tumor stage MF, and CD30- PCTCL, and is correlated with less aggressive disease [24]. The gene discussed is CD8A; the disease is neoplasm.